Tocchetti, Carlo GAmeri, Pietrode Boer, Rudolf AD'Alessandra, YuriRusso, MicheleSorriento, DanielaCiccarelli, MicheleKiss, BernadettBertrand, LucDawson, DanaFalcao-Pires, InesGiacca, MauroHamdani, NazhaLinke, Wolfgang AMayr, Manuelvan der Velden, JolandaZacchigna, SerenaGhigo, AlessandraHirsch, EmilioLyon, Alexander RGörbe, AnikóFerdinandy, PéterMadonna, RosalindaHeymans, StephaneThum, Thomas2021-07-182021-07-182020-09-01Tocchetti, C G, Ameri, P, de Boer, R A, D'Alessandra, Y, Russo, M, Sorriento, D, Ciccarelli, M, Kiss, B, Bertrand, L, Dawson, D, Falcao-Pires, I, Giacca, M, Hamdani, N, Linke, W A, Mayr, M, van der Velden, J, Zacchigna, S, Ghigo, A, Hirsch, E, Lyon, A R, Görbe, A, Ferdinandy, P, Madonna, R, Heymans, S & Thum, T 2020, 'Cardiac dysfunction in cancer patients : beyond direct cardiomyocyte damage of anticancer drugs. Novel cardio-oncology insights from the joint 2019 meeting of the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart', Cardiovascular Research, vol. 116, no. 11, pp. 1820-1834. https://doi.org/10.1093/cvr/cvaa2220008-6363ORCID: /0000-0003-2815-4469/work/160846653https://hdl.handle.net/2164/16833Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions please email: journals.permissions@oup.com.141172768engSDG 3 - Good Health and Well-beingCardio-OncologyCommon pathways in heart failure and cancerMulticellular an multiorgan mechanismsMulticellular and multiorgan mechanismsDOXORUBICIN-INDUCED CARDIOTOXICITYIMMUNE CHECKPOINT INHIBITORSINFLAMMATORY RESPONSESPRESERVED EJECTION FRACTIONEUROPEAN-SOCIETYLUNG-CANCERCHAIN FATTY-ACIDSCLONAL HEMATOPOIESISCARDIOVASCULAR-DISEASEHISTONE DEACETYLASEMulticellularMultiorgan mechanismsR MedicineCardiology and Cardiovascular MedicinePhysiology (medical)PhysiologyRJournal article10.1093/cvr/cvaa222http://www.scopus.com/inward/record.url?scp=85088271730&partnerID=8YFLogxK11611